From: Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis
Classification of type | Basic | Hematopoietic disorder | Infectious | |||
---|---|---|---|---|---|---|
Platelet count (×104/μl) | >12 | 0 p | >12 | 0 p | ||
8< – ≤12 | 1 p | 8< – ≤12 | 1 p | |||
5< – ≤8 | 2 p | 5< – ≤8 | 2 p | |||
≤5 | 3 p | ≤5 | 3 p | |||
≥30 % decrease w/in 24 h (*1) | +1 p | ≥30 % decrease w/in 24 h (*1) | +1 p | |||
FDP (μg/ml) | <10 | 0 p | <10 | 0 p | <10 | 0 p |
10≤ – <20 | 1 p | 10≤ – <20 | 1 p | 10 ≤ – <20 | 1 p | |
20≤ – <40 | 2 p | 20≤ -<40 | 2 p | 20≤ – <40 | 2 p | |
≥40 | 3 p | ≥40 | 3 p | ≥40 | 3 p | |
Fibrinogen (mg/dl) | >150 | 0 p | >150 | 0 p | ||
100< – ≤150 | 1 p | 100< – ≤150 | 1 p | |||
≤100 | 2 p | ≤100 | 2 p | |||
Prothrombin time ratio | <1.25 | 0 p | <1.25 | 0 p | <1.25 | 0 p |
1.25≤ – <1.67 | 1 p | 1.25≤ – <1.67 | 1 p | 1.25≤ – <1.67 | 1 p | |
≥1.67 | 2 p | ≥1.67 | 2 p | ≥1.67 | 2 p | |
Antithrombin (%) | >70 | 0 p | >70 | 0 p | >70 | 0 p |
≤70 | 1 p | ≤70 | 1 p | ≤70 | 1 p | |
TAT, SF or F1+2 | <2-fold of normal upper limit | 0 p | <2-fold of normal upper limit | 0 p | <2-fold of normal upper limit | 0 p |
≥2-fold of normal upper limit | 1 p | ≥2-fold of normal upper limit | 1 p | ≥2-fold of normal upper limit | 1 p | |
Liver failure (*2) | No | 0 p | No | 0 p | No | 0 p |
Yes | ˗3 p | Yes | ˗3 p | Yes | ˗3 p | |
DIC diagnosis | ≥6 p | ≥4 p | ≥6 p |